From Yahoo Finance: 2025-05-13 11:11:00

Verona Pharma plc (VRNA) is highlighted among the best performing healthcare stocks to buy now. President Trump’s executive order directs negotiation of Medicare drug prices. The order aims to cut healthcare costs and potentially lead to sector-specific tariffs. Drug makers have lobbied for delays in price negotiation eligibility. Medicare’s negotiation powers have been a contentious issue. The Trump administration aims to negotiate prices for 15 medications, including cancer and diabetes drugs. Verona Pharma plc (VRNA) is a UK-based biopharmaceutical company with a blockbuster drug Ohtuvayre for respiratory diseases. Analysts project sales potential to exceed $1 billion by 2029. Wells Fargo and Roth Capital raised price targets for VRNA based on strong drug sales performance. VRNA ranks 10th in the list of best healthcare stocks to buy now. For those seeking AI stocks with higher potential returns, consider checking out the report on the cheapest AI stock with substantial upside.

Read more: Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now